Johnson and Johnson gets Chinese nod to import psoriasis drug Tremfya Farhat Nasim29 Dec 2019 9:30 AM ISTJohnson and Johnson (JnJ) is positioning Tremfya as a better alternative to Novartis’s Cosentyx as it seeks to take market share away from the...
Siddhivinayak Trust to provide Rs 10 crore for pneumococcal vaccination drive Medical Dialogues Bureau29 Dec 2019 9:20 AM ISTThe Shree Siddhivinayak Ganapati Temple Trust has sanctioned Rs 10 crore for the Maharashtra government’s drive of giving pneumococcal vaccines to the...
OBI Pharma gets USFDA clearance for OBI-999 to treat pancreatic cancer Medical Dialogues Bureau29 Dec 2019 9:15 AM ISTNew Delhi: OBI Pharma, a Taiwan biopharma company, recently announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational...
Luye Pharma seeks USFDA nod for antidepressant drug LY03005 Medical Dialogues Bureau29 Dec 2019 9:00 AM ISTNew Delhi: Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for Injection (LY03004),...
Indira IVF to invest Rs 80 crore to expand presence in south India by 2020 Farhat Nasim28 Dec 2019 10:00 AM IST"With 81 centres currently spread across the county, we would be coming up with 15-20 new centres in south India. We would be investing around Rs...
IIT-Roorkee develops bioresorbable, economical ortho implants to heal bone fractures Farhat Nasim28 Dec 2019 9:40 AM ISTThe current therapeutic strategies for healing bone defects commonly suffer from the occurrence of bacterial contamination on the graft, resulting in...
Towa Pharma to acquire ESTEVE generic division Pensa Investments for 320 million euros Medical Dialogues Bureau28 Dec 2019 9:15 AM ISTThe purchase price of Pensa will be an all-cash deal with an upfront payment of 320 million euros. This acquisition is scheduled to be completed by...
Immunomedics BLA resubmission for sacituzumab govitecan to treat breast cancer accepted by USFDA Farhat Nasim28 Dec 2019 9:10 AM ISTSacituzumab govitecan has been awarded both Fast Track Designation and Breakthrough Therapy Designation by the USFDA, Immunomedics said in its recent...
Spring Bank Pharma halts dosing of Inarigivir patients in phase-2 trial to treat chronic HBV Medical Dialogues Bureau28 Dec 2019 9:00 AM ISTNew Delhi: Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the...
Granules India Independent Director C Parthasarathy resigns Medical Dialogues Bureau27 Dec 2019 3:55 PM ISTC Parthasarathy was serving the company since May 27, 2009. However, he submitted his resignation from the Board of Governors of Granules India Ltd....
Lupin Ankleshwar facility wins India Manufacturing Excellence Awards 2019 Medical Dialogues Bureau27 Dec 2019 9:30 AM ISTThe 2019 evaluation was done on the basis of an organisations’ Manufacturing Capability, Extended Supply Chain Reliability and Technology Adoption,...
Astellas Pharma acquires Xyphos for USD 665 million Farhat Nasim27 Dec 2019 9:25 AM ISTJapan's second-biggest drugmaker by sales paid $120 million upfront for Xyphos and the rest will be milestone payments, Astellas Pharma and Xyphos...
